Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteriaGünter U. Höglinger, Keith A. Josephs, Anthony E. Lang et al.|Movement Disorders|2017Cited by 2.3k
Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer’s diseaseMathias Jucker, Oliver Preische, Stephanie A. Schultz et al.|Nature Medicine|2019Cited by 948
Longitudinal cognitive and biomarker changes in dominantly inherited Alzheimer diseaseEric McDade, Robert A. Koeppe, Guoqiao Wang et al.|Neurology|2018Cited by 322
Four-repeat tauopathiesThomas W. Rösler, Günter U. Höglinger, Amir Tayaranian Marvian et al.|Progress in Neurobiology|2019Cited by 217
Cerebrospinal fluid proteomics define the natural history of autosomal dominant Alzheimer’s diseaseErik C. B. Johnson, Yudy Milena Leon, Shijia Bian et al.|Nature Medicine|2023Cited by 172